“…With many complex, multifactorial, perioperative conditions, however, only a moderate treatment effect size or relative risk reduction of 15% to 30% can be expected with a single intervention. 21,22 Furthermore, very clinically important, dichotomous perioperative complications (e.g., myocardial infarction, stroke, acute renal failure, sepsis, and death) occur at low event rates. Consequently, very large sample sizes of upward of 10,000 are needed to demonstrate statistical significance for a clinically important observed treatment effect.…”